GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zevra Therapeutics Inc (FRA:1GDA) » Definitions » Cyclically Adjusted Book per Share

Zevra Therapeutics (FRA:1GDA) Cyclically Adjusted Book per Share : €-22.61 (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Zevra Therapeutics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Zevra Therapeutics's adjusted book value per share for the three months ended in Mar. 2025 was €0.694. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €-22.61 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2025-05-28), Zevra Therapeutics's current stock price is €7.55. Zevra Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €-22.61. Zevra Therapeutics's Cyclically Adjusted PB Ratio of today is .


Zevra Therapeutics Cyclically Adjusted Book per Share Historical Data

The historical data trend for Zevra Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zevra Therapeutics Cyclically Adjusted Book per Share Chart

Zevra Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -24.01 -24.56

Zevra Therapeutics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.35 -25.48 -24.50 -24.56 -22.61

Competitive Comparison of Zevra Therapeutics's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Zevra Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zevra Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zevra Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zevra Therapeutics's Cyclically Adjusted PB Ratio falls into.


;
;

Zevra Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zevra Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.694/134.9266*134.9266
=0.694

Current CPI (Mar. 2025) = 134.9266.

Zevra Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201506 3.471 100.684 4.651
201509 -5.753 100.392 -7.732
201512 -10.255 99.792 -13.866
201603 -11.381 100.470 -15.284
201606 0.323 101.688 0.429
201609 -9.545 101.861 -12.643
201612 -19.370 101.863 -25.657
201703 -34.671 102.862 -45.479
201706 -38.163 103.349 -49.823
201709 -44.057 104.136 -57.084
201712 -53.058 104.011 -68.829
201803 -68.457 105.290 -87.726
201806 -71.947 106.317 -91.308
201809 -81.467 106.507 -103.205
201812 -35.397 105.998 -45.057
201903 -37.867 107.251 -47.639
201906 -40.005 108.070 -49.947
201909 -31.681 108.329 -39.459
201912 -29.494 108.420 -36.705
202003 -17.517 108.902 -21.703
202006 -13.288 108.767 -16.484
202009 -11.676 109.815 -14.346
202012 -12.032 109.897 -14.772
202103 2.485 111.754 3.000
202106 3.101 114.631 3.650
202109 3.171 115.734 3.697
202112 3.214 117.630 3.687
202203 3.205 121.301 3.565
202206 2.722 125.017 2.938
202209 2.746 125.227 2.959
202212 2.053 125.222 2.212
202303 1.968 127.348 2.085
202306 1.864 128.729 1.954
202309 1.746 129.860 1.814
202312 1.366 129.419 1.424
202403 1.073 131.776 1.099
202406 0.719 132.554 0.732
202409 1.181 133.029 1.198
202412 0.706 133.157 0.715
202503 0.694 134.927 0.694

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Zevra Therapeutics  (FRA:1GDA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Zevra Therapeutics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Zevra Therapeutics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Zevra Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
1180 Celebration Boulevard, Suite 103, Celebration, FL, USA, 34747
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Zevra Therapeutics Headlines

No Headlines